Globus Medical, Inc. (GMED) News

Globus Medical, Inc. (GMED): $53.18

0.79 (+1.51%)

POWR Rating

Component Grades













Filter GMED News Items

GMED News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

GMED News Highlights

  • GMED's 30 day story count now stands at 10.
  • Over the past 24 days, the trend for GMED's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
  • The most mentioned tickers in articles about GMED are AMP, TALK and SG.

Latest GMED News From Around the Web

Below are the latest news stories about GLOBUS MEDICAL INC that investors may wish to consider to help them evaluate GMED as an investment opportunity.

NuVasive (NUVA), GMED Merger Aids, Macro Woes Mar Growth

According to NuVasive (NUVA), the combined company is set to have an advanced commercial scale and portfolio of clinically proven solutions.

Yahoo | March 17, 2023

Is Now The Time To Put Globus Medical (NYSE:GMED) On Your Watchlist?

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Yahoo | March 12, 2023

Bear of the Day: NuVasive (NUVA)

Softer results for spinal surgery innovator plus questionable merger have dropped estimates and shares

Yahoo | March 2, 2023

Globus Medical, Inc. (NYSE:GMED) Q4 2022 Earnings Call Transcript

Globus Medical, Inc. (NYSE:GMED) Q4 2022 Earnings Call Transcript February 21, 2023 Operator: Thank you for standing by and welcome to Globus Medical’s Fourth Quarter and Full-Year 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. I will now turn […]

Yahoo | February 23, 2023

Globus Medical Full Year 2022 Earnings: EPS Misses Expectations

Globus Medical ( NYSE:GMED ) Full Year 2022 Results Key Financial Results Revenue: US$1.02b (up 6.8% from FY 2021). Net...

Yahoo | February 23, 2023

Globus Medical, Inc. (GMED) Q4 2022 Earnings Call Transcript

Globus Medical, Inc. (GMED)

Q4 2022 Earnings Conference Call

February 21, 2023 4:30 PM ET

Company Participants

Brian Kearns - Senior Vice President of Business Development and Investor Relations

Dan Scavilla - President and CEO

Keith Pfeil - Senior Vice President and Chief Financial Officer

Conference Call Participants

Shagun Singh - RBC Capital Markets

Matt Taylor - Jefferies

Matt Miksic - Barclays

Vik Chopra - Wells Fargo

David Saxon - Needham and Company

Steve Lichtman - Oppenheimer

Matthew O'Brien - Piper Sandler

Craig Bijou - Bank of America

Kyle Rose - Canaccord Genuity

Mathew Blackman - Stifel

Richard Newitter - Truist

Drew Ranieri...

SA Transcripts on Seeking Alpha | February 22, 2023

Globus Medical (GMED) Q4 Earnings Beat, Operating Margin Rises

Globus Medical (GMED) reports strong fourth-quarter sales growth amid currency headwinds and lingering COVID-19 impacts.

Yahoo | February 22, 2023

Globus Medical (GMED) Q4 2022 Earnings Call Transcript

Thank you for standing by, and welcome to Globus medical's fourth quarter and full year 2022 earnings conference call. Joining today's call from Globus Medical will be Dan Scavilla, president and CEO; and Keith Pfeil, chief financial officer.

Yahoo | February 22, 2023

Globus Medical (GMED) Tops Q4 Earnings Estimates

Globus Medical (GMED) delivered earnings and revenue surprises of 7.27% and 0.97%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 21, 2023

Globus Medical Reports Fourth Quarter and Full Year 2022 Results

AUDUBON, Pa., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2022. Fourth Quarter 2022: Worldwide net sales were $274.5 million, an increase of 9.8%, or 11.7% on a constant currency basisGAAP net income for the quarter was $50.1 millionGAAP diluted earnings per share (“EPS”) was $0.49 and non-GAAP diluted EPS was $0.59Non-GAAP adjusted EBITDA

Yahoo | February 21, 2023

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7261 seconds.